Phase II trials of the recombinant protein subunit vaccine approved for emergency use showed the vaccine is safe and can induce a strong immune response.
Phase II trial for di recombinant protein subunit vaccine wey dem appove for emergency use don show say di vaccine dey safe and e fit cause strong immune response.